🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 13 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/01/2015 | 32,88 | 33,01 | 32,10 | 32,18 | -1,70% | 2,77% | 275.876 |
| 14/01/2015 | 32,09 | 32,96 | 32,01 | 32,73 | +0,83% | 2,97% | 219.771 |
| 13/01/2015 | 32,29 | 33,49 | 32,16 | 32,46 | +0,97% | 4,13% | 430.566 |
| 12/01/2015 | 34,42 | 34,72 | 32,12 | 32,15 | -6,21% | 7,54% | 425.276 |
| 09/01/2015 | 34,37 | 34,64 | 33,09 | 34,28 | +0,02% | 4,50% | 557.684 |
| 08/01/2015 | 33,89 | 34,43 | 33,69 | 34,27 | +2,23% | 2,19% | 472.404 |
| 07/01/2015 | 32,78 | 33,61 | 32,08 | 33,52 | +3,15% | 4,66% | 311.623 |
| 06/01/2015 | 33,34 | 33,72 | 31,99 | 32,50 | -2,40% | 5,20% | 414.696 |
| 05/01/2015 | 33,20 | 34,18 | 32,99 | 33,30 | -0,65% | 3,59% | 335.027 |
| 02/01/2015 | 33,48 | 34,20 | 32,84 | 33,52 | +0,98% | 4,06% | 334.706 |
| 31/12/2014 | 32,60 | 33,66 | 32,60 | 33,19 | +1,90% | 3,25% | 382.636 |
| 30/12/2014 | 32,53 | 33,08 | 32,35 | 32,58 | -0,29% | 2,24% | 243.496 |
| 29/12/2014 | 33,08 | 33,60 | 32,48 | 32,67 | -1,11% | 3,38% | 200.535 |
| 26/12/2014 | 32,55 | 33,49 | 32,55 | 33,04 | +2,26% | 2,89% | 207.749 |
| 24/12/2014 | 31,54 | 33,53 | 31,54 | 32,31 | +2,41% | 6,31% | 116.057 |
| 23/12/2014 | 33,82 | 34,01 | 31,50 | 31,55 | -6,37% | 7,41% | 336.149 |
| 22/12/2014 | 32,49 | 33,80 | 32,35 | 33,69 | +3,23% | 4,47% | 295.914 |
| 19/12/2014 | 32,46 | 33,13 | 32,38 | 32,64 | +0,36% | 2,31% | 1.203.853 |
| 18/12/2014 | 32,99 | 32,99 | 32,29 | 32,52 | +0,17% | 2,14% | 491.159 |
| 17/12/2014 | 32,14 | 32,62 | 31,82 | 32,46 | +0,97% | 2,50% | 620.842 |
| 16/12/2014 | 32,44 | 33,15 | 32,00 | 32,15 | -1,34% | 3,56% | 379.911 |
| 15/12/2014 | 33,06 | 33,72 | 32,20 | 32,59 | -0,53% | 4,59% | 443.710 |
| 12/12/2014 | 33,11 | 33,41 | 32,69 | 32,76 | -2,54% | 2,17% | 404.758 |
| 11/12/2014 | 33,55 | 34,36 | 33,33 | 33,62 | +0,99% | 3,09% | 272.670 |
| 10/12/2014 | 34,19 | 34,45 | 32,84 | 33,29 | -2,65% | 4,69% | 496.449 |
| 09/12/2014 | 34,02 | 34,60 | 33,72 | 34,19 | -0,98% | 2,59% | 453.489 |
| 08/12/2014 | 33,84 | 34,72 | 33,76 | 34,53 | +2,31% | 2,82% | 467.435 |
| 05/12/2014 | 33,33 | 34,02 | 33,29 | 33,75 | +1,23% | 2,19% | 461.023 |
| 04/12/2014 | 34,04 | 34,48 | 33,06 | 33,34 | -2,43% | 4,16% | 358.271 |
| 03/12/2014 | 34,36 | 34,75 | 33,88 | 34,17 | -0,81% | 2,54% | 413.093 |